Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities
| Autor: | Aryavarta M. S. Kumar, Anna Wu, M.Z. Kharouta, Aashish D. Bhatt, Mitchell X. Machtay, Alok Deshane, Gi-Ming Wang, Serah Choi, N. Damico |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Response rate (survey)
Government Telemedicine medicine.medical_specialty Descriptive statistics Coronavirus disease 2019 (COVID-19) business.industry R895-920 Neoplasms. Tumors. Oncology. Including cancer and carcinogens Likert scale Medical physics. Medical radiology. Nuclear medicine Oncology Family medicine Pandemic Research Letter Medicine Radiology Nuclear Medicine and imaging business RC254-282 Reimbursement |
| Zdroj: | Advances in Radiation Oncology Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100835-(2022) |
| ISSN: | 2452-1094 |
| Popis: | Purpose: During the COVID-19 pandemic, telemedicine became an attractive alternative to in-person appointments. The role of telemedicine in patients who undergo frequent on-site treatment, such as radiation therapy, is unclear. The purpose of this study was to examine telemedicine use, physician satisfaction, and barriers to continued use in radiation oncology. Methods and Materials: An anonymous, electronic survey was distributed to radiation oncologists internationally between June and October 2020. Respondents described demographic and practice characteristics, and a 5-point Likert scale assessed provider satisfaction, ease of use, and overall utility of telemedicine. Analyses include descriptive statistics and subgroup comparisons using the χ2 test and Fisher's exact test. Results: The response rate was 4.3%. Two hundred thirty-two respondents completed the survey, 63.8% of whom were male, 52.6% aged 50 or younger, and 78.0% from the United States. Only 14.2% used telemedicine previously, which increased to 93.1% during COVID-19. Among all telemedicine users, usage rates were 77.9% for initial consultations, 97.2% for follow-up visits, and 35.9% for on-treatment visits. Of the respondents, 69.8% reported that |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|